BioDelivery Sciences International, Inc.
BioDelivery Sciences Announces Positive Phase 2 Pain Trial Results for BEMA Buprenorphine
Published in Mental Health Business Week, January 9th, 2010
The Phase 2 clinical trial was a double-blind, randomized, placebo-controlled study of BEMA Buprenorphine for the treatment of pain following third molar extraction (dental surgery), a common study used to assess the efficacy of potential products to treat pain. Subjects received one of the following treatments: BEMA Buprenorphine, oral 5mg oxycodone, or placebo. BEMA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Afferent Pharmaceuticals
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series a Financing - American Psychological Association
APA Statement on Senate Passage of Health Care Reform Legislation - Atomoxetine Therapy
Study findings from Eli Lilly and Company broaden understanding of atomoxetine therapy - Attention Deficit Hyperactivity Disorder
Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page - California Association of Marriage and Family Therapists;
Rethinking Resolutions: Making Your Emotional and Mental Health Top Priority in 2010 - California Association of Psychiatric Technicians
State Psychiatric Technicians Say Goodbye to Sierra Vista Developmental Center - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
